Cognitive and motor performance measures are commonly employed in multiple sclerosis
(MS) research, particularly when the purpose is to determine the efficacy of treatment. The …

Multiple sclerosis (MS) is a progressive disease of the CNS that is characterised by
widespread lesions in the brain and spinal cord. MS results in motor, cognitive, and …

Background: There is limited and inconsistent information on the clinical determinants of
cognitive impairment (CI) in multiple sclerosis (MS). Objective: The aim of this study was to …

Prevalence estimates of cognitive impairment in multiple sclerosis (MS) range from 40% to
65%, depending on the research setting. Cognitive dysfunction virtually encompasses all the …

The relationships between cognitive impairment that exist during the clinical course of
multiple sclerosis (MS) remain poorly described. The effect of disease duration has been …

Cognitive impairment is common in multiple sclerosis (MS), especially when assessed by
neuropsychological tests that emphasize mental processing speed, episodic memory, and …

Background: Information processing speed (IPS) is a prevalent cognitive impairment in
multiple sclerosis (MS). Objectives: This review aims to summarize the methods applied to …

Cognitive impairment is a common and debilitating feature of multiple sclerosis (MS) that
has only recent gained considerable attention. Clinical neuropsychological studies have …

The causes of incomplete remyelination in progressive multiple sclerosis are unknown, as
are the pathological correlates of the different clinical characteristics of patients with primary …

Cognitive impairment (CI) is common and debilitating in patients with multiple sclerosis.
However, little is known about how different disease courses affect CI, impeding prognosis …